The cell cycle is a sequence of events that a cell moves through as it grows and divides into two daughter cells, and it breaks down into four main phases: G1 (first gap), S (synthesis), G2 (second gap), and M (mitosis). These phases are not a simple timer ticking down to division. They are gated by internal checkpoints that inspect the cell’s DNA, size, and surroundings before letting it move forward. Understanding what happens at each phase, and what keeps the whole process in check, sheds light on everything from wound healing to cancer.
G1 and the Decision to Divide
G1 is the longest and most variable phase. During G1, a cell grows in size, produces proteins, and responds to signals from its environment. Growth factors, nutrient availability, and physical contact with neighboring cells all feed into whether the cell will commit to another round of division or step out of the cycle entirely. The critical moment in G1 is the restriction point, a molecular threshold after which the cell no longer needs external growth signals to keep going. Once past this point, the cell is committed to dividing.
The restriction point is governed by a protein called Rb (retinoblastoma protein) and its state of phosphorylation. Single-cell experiments have shown that cells sort themselves into two groups almost immediately after completing the previous division: one group enters G1 with high activity of the enzyme CDK2 and heavily phosphorylated Rb, meaning they never truly “uncross” the restriction point and are already committed to cycling again. The other group exits mitosis into a genuinely uncommitted state and must receive fresh signals before proceeding.1PubMed Central. Control of the Restriction Point by Rb and p21 This split means that in a population of dividing cells, not everyone is making a fresh “go or stop” decision each time around. Some cells are essentially pre-committed.
S Phase and DNA Replication
Once a cell passes the restriction point and reaches S phase, it copies its entire genome. Human cells have roughly six billion base pairs of DNA packed into 46 chromosomes, and every one of those base pairs needs to be faithfully duplicated. Replication starts at thousands of origins scattered across the chromosomes, with molecular machinery opening the DNA double helix and building a complementary strand on each side.
A key concern during S phase is making sure each stretch of DNA gets copied exactly once. Copy a region twice and you get extra genetic material; miss a region and you lose genes. The cell handles this through a licensing system. Before S phase begins, proteins assemble at replication origins to form pre-replicative complexes, essentially giving each origin a one-time-use permit to fire. One of the central players in this licensing is a protein called Cdt1, whose accumulation at the end of the previous cycle helps load the replication machinery. A partner protein called Geminin acts as a master regulator, promoting Cdt1 buildup when it is needed but inhibiting Cdt1’s function during G2 so that origins cannot fire a second time.2PubMed Central. Geminin deploys multiple mechanisms to regulate Cdt1 before cell division thus ensuring the proper execution of DNA replication When Geminin is lost at the wrong moment, cells can re-replicate their DNA and activate emergency checkpoint responses.
G2 and Preparing for Mitosis
After DNA replication wraps up, the cell enters G2, a gap phase devoted to final preparations. The cell continues to grow, synthesizes proteins it will need for mitosis, and runs a thorough quality check on its freshly copied DNA. Any replication errors or damage detected here trigger checkpoint pathways that stall the cycle until repairs are made.
The transition from G2 into mitosis hinges on activation of a molecular switch built around the CDK1 enzyme paired with cyclin B. This complex is the master trigger for mitosis, but it is kept inactive during G2 by inhibitory phosphorylation. The enzyme that flips the switch is a phosphatase called CDC25. Specifically, CDC25B becomes active in the nucleus during late S phase but only moves into the cytoplasm during late G2, where it activates the CDK1/cyclin B complex.3PubMed Central. Phosphatases and Kinases Regulating CDC25 Activity in the Cell Cycle: Clinical Implications of CDC25 Overexpression and Potential Treatment Strategies A related family member, CDC25C, also contributes to full activation of CDK1/cyclin B and plays a role in the G2/M checkpoint that pauses cells if DNA damage is detected.4PubMed Central. The role of CDC25C in cell cycle regulation and clinical cancer therapy: a systematic review Both CDC25B and CDC25C are required: blocking either one can stall entry into mitosis.
Mitosis and Cytokinesis
M phase is the dramatic finale, the actual splitting of one cell into two. It unfolds in stages: the chromosomes condense and become visible, the nuclear envelope breaks down, a spindle apparatus made of protein fibers (microtubules) forms, and each chromosome is hauled to opposite sides of the cell. This alignment step depends on connections between the spindle fibers and specialized structures on each chromosome called kinetochores. The Ndc80 complex is one of the key molecular bridges at the kinetochore. When Ndc80 or its partner Nuf2 are depleted in vertebrate cells, stable bundles of kinetochore microtubules fail to form, and chromosomes cannot be properly sorted.5PubMed Central. Kinetochore–spindle microtubule interactions during mitosis
After the chromosomes are separated, the cell physically pinches in half through cytokinesis. The driving force is a contractile ring made of actin and myosin filaments that assembles at the cell’s equator and tightens like a drawstring. The small signaling protein RhoA is the trigger for this ring: activating RhoA locally at the right spot is enough to induce a functional contractile ring and furrow, even independent of spindle position.6PubMed Central. Local RhoA activation induces cytokinetic furrows independent of spindle position and cell cycle stage The result is two daughter cells, each with a complete copy of the genome, ready to enter G1 and start the process over or exit into a non-dividing state.
The Spindle Assembly Checkpoint
The most dramatic quality-control moment in the entire cycle is the spindle assembly checkpoint, which operates during mitosis itself. This checkpoint monitors whether every chromosome is properly attached to the spindle and under tension from microtubules pulling in opposite directions. If even a single chromosome is unattached or incorrectly attached, the checkpoint halts the cell before it separates its chromosomes.
The mechanism works by blocking a molecular machine called the anaphase-promoting complex (APC). The APC, when activated by a partner called Cdc20, triggers the separation of sister chromatids. Two checkpoint proteins, Mad2 and BubR1, work together to keep Cdc20 in check. BubR1 binds directly to Cdc20 and is roughly twelve-fold more potent than Mad2 at inhibiting it, but the two proteins promote each other’s binding and work synergistically at normal cellular concentrations to shut down the APC completely.7PubMed. Checkpoint protein BubR1 acts synergistically with Mad2 to inhibit anaphase-promoting complex Together, they assemble into the mitotic checkpoint complex, which holds the cell in metaphase until every chromosome is accounted for.8PubMed Central. Regulation of mitotic progression by the spindle assembly checkpoint
When this checkpoint is weakened, the consequences are severe. In cervical cancer cell lines, for example, reduced levels of Mad2 and BubR1 increased malignant behavior and drug resistance by compromising spindle assembly checkpoint signaling.9PubMed. Downregulation of Mad2 and BubR1 increase the malignant potential and nocodazole resistance by compromising spindle assembly checkpoint signaling pathway in cervical carcinogenesis This is one of the clearest links between a specific checkpoint failure and cancer progression.
The DNA Damage Checkpoints
While the spindle checkpoint guards mitosis, DNA damage checkpoints can halt the cell at multiple points earlier in the cycle. If DNA is broken or damaged by radiation, chemicals, or replication errors, sensor kinases detect the problem and trigger signaling cascades. Two major branches handle different types of damage: one responds primarily to double-strand breaks, and the other to single-strand breaks or bulky lesions. Both branches converge on CDC25, the same phosphatase family that activates the CDK1/cyclin B switch described earlier. Checkpoint-driven phosphorylation inactivates CDC25, keeping the brakes on.10PubMed Central. Kinases that control the cell cycle in response to DNA damage: Chk1, Chk2, and MK2
Another layer of this response involves the protein p21, a broad inhibitor of the CDK enzymes that drive the cell cycle forward. When DNA damage is detected, p21 levels rise, and the result is a firm pause in the cycle. p21 can be induced through both p53-dependent and p53-independent pathways, giving the cell more than one route to pull the emergency brake.11PubMed Central. Multiple functions of p21 in cell cycle, apoptosis and transcriptional regulation after DNA damage If the damage is too severe to fix, these same pathways can redirect the cell toward self-destruction (apoptosis) or permanent arrest (senescence) rather than letting it limp forward with broken DNA.
Stepping Out of the Cycle
Not every cell keeps cycling. Many cells in the body leave the active cycle and enter a resting state called G0. Neurons, mature muscle cells, and most liver cells spend their lives in G0, carrying out their specialized functions without dividing. This exit is reversible in some cases: liver cells can re-enter the cycle after injury, and immune cells jump back in when they encounter a pathogen. But in other cases the exit is permanent.
There are two importantly different forms of “not dividing.” Quiescence is a reversible pause. The cell remains healthy and metabolically active but has dialed back growth-related programs and can be coaxed back into dividing by the right signals. Senescence, on the other hand, is a permanent arrest. Senescent cells are metabolically active, often more so than quiescent ones, and they secrete a characteristic cocktail of inflammatory signals. Researchers have found that one way to distinguish the two states is by looking at markers of protein synthesis: senescent cells maintain active protein-making machinery, while quiescent cells shut it down.12PubMed Central. Different Stages of Quiescence, Senescence, and Cell Stress Identified by Molecular Algorithm Based on the Expression of Ki67, RPS6, and Beta-Galactosidase Activity Gene expression studies have also identified distinct molecular signatures for each state, including a secretory profile unique to quiescent cells that had not been widely appreciated until recently.13PubMed. Differentially regulated gene expression in quiescence versus senescence and identification of ARID5A as a quiescence associated marker
When the Physical Environment Decides
Whether a cell cycles or stays put is not purely a matter of internal signals. The physical surroundings matter. Cells grown on soft surfaces, mimicking certain tissue environments, barely enter S phase even when flooded with growth factors. The same cells on stiffer surfaces divide readily. This stiffness-dependent control has been observed in mammary epithelial cells, vascular smooth muscle cells, fibroblasts, and bone-forming cells, suggesting the effect is widely conserved.14Current Biology. Cell-Cycle Control by Physiological Matrix Elasticity and In Vivo Tissue Stiffening
The connection runs through a protein called focal adhesion kinase (FAK), which senses mechanical cues from the extracellular matrix. When FAK is activated above a threshold, it feeds into the same cyclin D pathway that growth factors use, pushing the cell past the restriction point. Modeling work has shown that increased FAK activation alone, without growth factors, can flip a cell from arrest into proliferation.15Interface Focus. The balance between cell cycle arrest and cell proliferation: control by the extracellular matrix and by contact inhibition This has real implications for understanding tumors: cancerous tissue is often stiffer than normal tissue, and that stiffness may be actively contributing to uncontrolled proliferation, not just resulting from it.
Variant Cycles in Specialized Cells
The standard four-phase cycle is not the only version that exists. Some cells run abbreviated or modified cycles depending on their developmental role. In early embryos of most animals, the first divisions after fertilization are extraordinarily fast, skipping the G1 and G2 gap phases almost entirely. These rapid cleavage divisions rely on chemical waves and cytoplasmic flows to coordinate events across the large expanse of the embryo.16PubMed Central. Cell cycle control during early embryogenesis
Another variant is endoreplication, in which cells copy their DNA without dividing. This produces cells with more than the standard two copies of each chromosome. Endoreplication comes in two flavors: endocycling, where the cell alternates between S phase and a gap phase with no mitosis at all, and endomitosis, where the cell enters mitosis but aborts before dividing and then re-enters S phase.17PubMed Central. Endoreplication and polyploidy: insights into development and disease These strategies are not mistakes. Megakaryocytes in your bone marrow use endomitosis to become massive polyploid cells that can shed thousands of platelets. Placental trophoblast giant cells use endocycling to grow large enough to support implantation. In plants, endoreplication is widespread and plays a major role in growth and development.
CDK Inhibitors and Cancer Therapy
Because the cell cycle is so tightly linked to proliferation, it has become a major target for cancer drugs. The enzymes CDK4 and CDK6, which drive cells through G1, are among the most therapeutically successful targets. Small-molecule inhibitors of CDK4/6 have become a cornerstone in treating hormone receptor-positive breast cancers and are in clinical trials for many other tumor types.18PubMed Central. CDK4 and CDK6 kinases: From basic science to cancer therapy These drugs essentially force cancer cells to stay in G1, preventing them from reaching S phase and copying their DNA.
The logic is straightforward: many cancers have mutations that deactivate Rb or overactivate the CDK4/6–cyclin D pathway, making the restriction point too easy to cross. CDK4/6 inhibitors restore that barrier. Their success in breast cancer has been among the clearest examples of basic cell-cycle biology translating directly into patient care. The challenge ahead is figuring out which other cancers will respond similarly, since the wiring of the G1 checkpoint varies across tumor types.
Watching Cells Cycle in Real Time
For decades, studying the cell cycle meant catching snapshots: staining a population of cells, counting how many were in S phase, and inferring timing from bulk measurements. That changed with the development of FUCCI (Fluorescent Ubiquitin Cell Cycle Indicator) technology, which lets researchers watch individual living cells transition through the cycle in real time. FUCCI takes advantage of the same molecular oscillators the cell uses internally. Two fluorescent proteins are fused to fragments of Cdt1 and Geminin, which the cell naturally builds up and destroys at different cycle stages. Cells in G1 glow one color, cells in S/G2 glow another, and the transition between them shows up as a brief overlap of both colors.19PubMed Central. Cell cycle visualization tools to study cardiomyocyte proliferation in real-time
FUCCI has been adapted to flies, fish, mice, and plants, making it available across a wide range of biological research.20PubMed Central. FUCCI sensors: powerful new tools for analysis of cell proliferation More recently, additional reporter systems have emerged, including kinase translocation reporters and DNA replication foci-based tools, each offering different windows into cycle progression.21PubMed Central. A concise guide to fluorescent cell cycle reporters for live-cell imaging One practical application of these tools is in cardiac research, where understanding whether heart muscle cells are truly dividing or just growing larger is critical for developing regenerative therapies. FUCCI and related reporters have made it possible to distinguish real division from other events that can mimic it.
An Ancient and Flexible Blueprint
The basic architecture of the cell cycle is extremely old. Comparisons between budding yeast and mammals reveal strikingly similar network structures controlling the G1-to-S transition, even though many of the individual proteins filling those roles have unrelated amino acid sequences. This suggests that what evolution has truly conserved is the network’s wiring diagram and its dynamic behavior, not necessarily the identity of the molecular parts.22PubMed Central. Evolution of networks and sequences in eukaryotic cell cycle control Plants, for instance, use cell cycle regulators like Rb, E2F, and cyclins A and D that appear to have been lost in yeast, hinting that the last common ancestor of all eukaryotes ran a more complex version of the cycle than yeast does today.
This evolutionary flexibility explains why the cell cycle can accommodate such diversity. A yeast cell divides in about ninety minutes. A fly embryo cell can go from one division to the next in eight minutes. A human liver cell may sit in G0 for years. The underlying logic of checkpoints gating transitions between growth, replication, and division remains the same, but the timing, the specific proteins, and the emphasis on particular phases can be tuned to fit almost any biological need. That adaptability is probably why the system has persisted, with variations, across more than a billion years of eukaryotic life.